LYT-200
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Solid Tumors
Phase 1/2Active
Key Facts
Indication
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Solid Tumors
Phase
Phase 1/2
Status
Active
Company
About PureTech Health
PureHealth Health is a biotherapeutics company with a proven track record of translating scientific innovation into clinical and commercial value. It employs a distinctive operational model, acting as a biotech 'studio' that conceives, founds, and advances new companies around specific scientific programs. This approach has generated 29 therapeutic candidates, including three that have progressed from inception at PureTech to FDA approval. The company's strategy focuses on unlocking the potential of validated biology by improving efficacy, enabling oral delivery, or enhancing tolerability.
View full company profile